Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis.

From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy.

Regrowth of Eyebrows in a Previous Steroid Non-Responder With Alopecia Universalis After Ritlecitinib Treatment.

Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy.

Clinical characteristics, subtype classification, and prognostic factors of ophiasis: A retrospective study of 150 patients with therapeutic implications.

Stem cell-based therapies for alopecia areata: a narrative review.

Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib.

Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo-A Case Report.

Remission of Alopecia Areata Post-colectomy in a Patient with Crohn's Disease.

Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine.

[Efficiency and safety of JAK inhibitors for alopecia totalis and alopecia universalis].

[Efficacy and safety of baricitinib treatment in alopecia areata: a retrospective analysis].

Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older.

Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report.

Efficacy of oral tofacitinib in moderate to severe alopecia areata, totalis and universalis at the tertiary care hospital, Karachi.

British Association of Dermatologists living guideline for managing people with alopecia areata 2025.

Alopecia universalis following human papillomavirus vaccine administration: a case report.

Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience.

Successful management of therapy-resistant chronic refractory atopic dermatitis and alopecia universalis with oral tofacitinib in a girl.

Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement.

Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.

Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study.

Post-COVID-19 Alopecia Universalis: Autoimmune Hair Loss and the Challenge of Relapse Management.

Association between alopecia areata and cardiovascular disease: a systematic review and meta-analysis.

Two pediatric cases of alopecia universalis with concomitant atopic dermatitis successfully treated with baricitinib.

Treatment outcomes and considerations for topical immunotherapy in patients with alopecia totalis and alopecia universalis.

Upadacitinib for Alopecia: Current Evidence and Clinical Insights.

Vogt-Koyanagi-Harada Disease in which Poliosis and Alopecia Occurred after a Long Period of Time.

Atrichia Congenita with Papular Lesions: A Report of Rare Case Showing "Cluster of Stars' Appearance on Dermoscopy".

Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy.

Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.

Combination of oral tofacitinib and oral mini-pulse with betamethasone (T-OMP) for the successful treatment of long-standing alopecia universalis: A real-world experience in a recalcitrant disease.

Autoimmune Polyglandular Syndrome Type 2 Presentation with Alopecia Universalis, Hashimoto's Disease, and Addison's Disease.

Correlation between increased total serum IgE levels and clinical features in alopecia areata patients.

Informed clinical decisions by outfoxing human FOXN1 variants.

Oral minoxidil treatment of alopecia areata.

Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications.

Assessment of Vascular Circulation in Alopecia Areata Using the FMSF Technique.

Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.

Friend or foe: A systematic review of dupilumab and alopecia areata.

Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark.

Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study.

Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients.

Impact of Janus Kinase Inhibitors on Psychiatric and Sleep Outcomes in Alopecia Areata: A Real-World Multicenter Cohort Study.

The Efficacy of Off-Label Abrocitinib in Alopecia Areata: A Systematic Review.

Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report.

Alopecia areata in solid organ transplant recipients: A retrospective analysis.

A First Case of Complete Resolution of Hair Loss in a Patient With Rheumatoid Arthritis and Concomitant Alopecia Universalis Treated With Filgotinib.

Efficacy of baricitinib in moderate alopecia areata, severe alopecia areata, alopecia totalis, and alopecia universalis: A real-world comparative study.

Alopecia universalis and type 1 diabetes mellitus both successfully controlled with baricitinib in a patient with autoimmune polyglandular syndrome type 3A.

Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients.

Epidemiology of Pediatric Alopecia Areata.

Systemic Therapies for Pediatric Alopecia Areata.

Alopecia Universalis: Never Give Up?

Switching JAK inhibitors: evaluating baricitinib's effectiveness in alopecia areata after tofacitinib failure.

Common variable immunodeficiency 10 due to a novel variant of NFKB2 and presenting as alopecia universalis and vitiligo.

Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights.

Baricitinib-Induced Remission of Alopecia Universalis in a Child with NFKB2-Associated Immune Dysregulation.

Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report.

Idiopathic Developmental Dysplasia of Hip in a Female Child with a Rare Epidermal Syndrome- A Case Report.

Alopecia Areata Following the Use of Belimumab in a Patient with Systemic Lupus Erythematosus and Arthritis Who Responded Well to Baricitinib: A Case Report.

A scoping review of alopecia areata and its relationship to COVID-19 vaccinations.

Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy.

Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review.

Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2.

Biallelic pathogenic variants in the LSS gene cause congenital alopecia-cataract syndrome.

British Association of Dermatologists living guideline for managing people with alopecia areata 2024.

Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.

Myeloproliferative disorder associated with alopecia universalis.

Patterns of misdiagnosis in adults with alopecia areata: an analysis using the NIH's All of Us database.

Comparative investigation of immune-related biomarkers related to alopecia areata subtypes.

Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib.

Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study.

Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib.

Tofacitinib in the Management of Alopecia Universalis.

The Association between Number of Follicular Stelae and Severity and Treatment Response of Alopecia Areata Cases: A Retrospective Study.

Tofacitinib in Pediatric Alopecia Areata Totalis and Alopecia Universalis: A Retrospective Analysis From India.

Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial.

Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient.

Emergence of Janus kinase inhibitors led to increase in proportion of severe alopecia areata patients receiving treatment: A retrospective cohort study.

Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis.

Diphenylcyclopropenone alleviates trachyonychia in alopecia universalis.

"Hair is your crown and glory" - Black women's experiences of living with alopecia and the role of social support.

The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995-2016.

C-reactive protein as a novel biomarker for vitamin D deficiency in alopecia areata.

Efficacy and safety of topical corticosteroid treatment under occlusion for severe alopecia areata in children: a single-centre retrospective analysis.

A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis.

A rare case of alopecia universalis.

European expert consensus statement on the systemic treatment of alopecia areata.

Corneal Transplant Rejection and Alopecia Areata Universalis in a Patient With Severe Atopic Dermatitis on Dupilumab.

Successful Remission with Combination of Diphenylcyclopropenone and Apremilast in Refractory Extensive Alopecia Areata.

Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth.

Intralesional Pentoxifylline Injection Versus Triamcinolone Acetonide in Treating localized Alopecia Areata: A Comparative Study.

Effective management Alopecia totalis by Ayurveda - A case report.

Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report.

The Efficacy and Adverse Effects of Corticosteroid Pulse Therapy in Alopecia Areata: A Review Article.

The Gut and Skin Microbiome in Alopecia: Associations and Interventions.

Post-Traumatic Stress Disorder in Patients with Alopecia Areata: A Survey Study in the USA.

Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib.

Treatments for alopecia areata: a network meta-analysis.

Alopecia areata: What's new in the epidemiology, comorbidities, and pathogenesis?

Modified Mediterranean Diet With Anti-Inflammatory Features and Oral Butyrate Supplementation Appears to Have No Effect in Cases of Alopecia Areata Universalis and Totalis: Experience With 20 Patients.

Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2.

Treatment Patterns for Alopecia Areata in the US.

Survey of pediatric dermatologist views on treatment for alopecia areata.

Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study.

Commonly Associated Disorders with Complete Scalp Alopecia in Early Childhood: A Review.

Overall and demographic subgroup incidences of alopecia areata, alopecia totalis, and alopecia universalis in the United States.

Alopecia Universalis in an Elderly Chinese Man Induced by Sacubitril/Alisartan, a Novel Angiotensin Receptor-Neprilysin Inhibitor.

Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis.

Janus kinase inhibitors for alopecia areata.

Treatment of Alopecia Universalis in a Child with Down Syndrome.

Successful treatment of alopecia universalis with abrocitinib: a case report.

Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review.

Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report.

A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study.

Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database.

Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database.

Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy.

A retrospective study on the clinical characteristics and prognosis of alopecia totalis and universalis: An update on prognosis.

Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review.

The Association between the Number of Follicular Stelae and Severity and Treatment Response of Alopecia Areata Cases: A Retrospective Study.

The frequency of fatty liver in patients with alopecia areata: A case-control study.

Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review.

Successful treatment of concomitant alopecia universalis and Crohn's disease with upadacitinib: A case report.

Assessing Patient's Values When Selecting Treatments for Alopecia Areata: A Cross-Sectional Survey Study.

Possible mechanisms mediating complete regrowth of hair following scalp tattooing in alopecia universalis.

Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.

Overall and Racial and Ethnic Subgroup Prevalences of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.

A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme.

Hydroxychloroquine for granuloma annulare: A case report on secondary hair growth in alopecia universalis.

Baricitinib effectiveness in patients with alopecia universalis and rheumatoid arthritis.

An impressive case of alopecia universalis after COVID-19 vaccination: a coincidental finding or a consequence?

Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata.

Dupilumab as a Therapeutic Approach in Alopecia Universalis.

Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients.

FOXN1 Gene Considerations in Severe Combined Immunodeficiency Treatment in Children.

Complete regrowth of hair following scalp tattooing in a patient with alopecia universalis.

Effective treatment of alopecia universalis with oral upadacitinib.

Clinical response to oral tofacitinib in pediatric patients with alopecia areata.

Epidemiology of alopecia areata in Hispanic/Latinx patients.

Anxiety, depression, and quality of life in children and adults with alopecia areata: A systematic review and meta-analysis.

Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata.

Treatment of alopecia areata of the beard with baricitinib.

A Practical Approach to the Treatment of Alopecia Areata.

Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors.

Alopecia Universalis after Treatment with Simvastatin and Ezetimibe: Affects on Family.

Treatment of longstanding alopecia areata universalis of the eyebrows/facial hair with oral and topical tofacitinib.

Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis.

The Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review.

Real-world experience and long-term evaluation of tofacitinib in refractory alopecia areata: A prospective, open-label, single-center study in Asian Arab population.

A first case of childhood chronic inflammatory demyelinating polyneuropathy associated with alopecia universalis.

Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid.

Improvement of atopic dermatitis and alopecia universalis with dupilumab.

Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?

Assessment of alopecia areata universalis successfully treated with upadacitinib.

Topical diphenylcyclopropenone plus topical 0.5% anthralin versus topical diphenylcyclopropenone alone for the treatment of chronic extensive alopecia areata: A split-scalp, double-blind, controlled study.

Alopecia universalis with unusual histopathologic features after vaccination with ChAdOx1 nCoV-19 (AZD1222).

Is there a link between alopecia areata and gut?

Not just thinning: A case of alopecia universalis after mild COVID-19.

Economic Impact of Home-Use versus Office-Use Diphenylcyclopropenone in Extensive Alopecia Areata.

Successful treatment of chronic severe alopecia areata with abrocitinib.

Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata.

A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib.

Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework.

All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States.

Could mean platelet volume be used as a marker for activity and severity index of alopecia areata?

Topical bimatoprost in the treatment of eyelash loss in alopecia totalis and universalis: A prospective, open-label study.

Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib.

A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.

Alopecia Universalis Associated with Hyperthyroidism Treated with Azathioprine and Hydroxychloroquine: A Case Report.

Alopecia universalis improvement following risankizumab in a psoriasis patient.

Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.

Successful Therapy of Alopecia Universalis Using a Combination of Systemic Methotrexate and Corticosteroids and Topical 5% Minoxidil.

Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib.

Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis.

Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1.

Recovery of Alopecia Universalis with Associated Nail Dystrophy Treated with Tofacitinib: A 6-year-old Child's Case Report.

Treatment of alopecia totalis/universalis/focalis with vitamin D and analogs: Three case reports and a literature review.

Ritlecitinib: an investigational drug for the treatment of moderate to severe alopecia areata.

Hair regrowth and maintenance in alopecia universalis patient treated with nonablative Er:YAG laser.

Estimation of CD3, CD4, and CD8 in Iraqi patients with alopecia areata and alopecia universalis.

Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population.

The close resemblance between patients with severe alopecia areata and those with cancer: What hair tells us about wellness or grave illness.

It is all alopecia areata: It is time to abandon the terms alopecia totalis and alopecia universalis.

Tofacitinib Treatment in Patients With Active COVID-19 Infection.

[Hair growth with dupilumab in alopecia areata universalis and atopic dermatitis].

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis.

Hairless Gene Nonsense Mutations in Alopecia Universalis: A Case Report.

Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Alopecia Areata: An Autoimmune Disease of Multiple Players.

Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients.

Association of Alopecia Areata With Attention-Deficit/Hyperactivity Disorder Stimulant Medication: A Case-Control Study.

Adiponectin as a novel biomarker of disease severity in alopecia areata.

Atrichia with papular lesions: a differential diagnosis of alopecia universalis not to be missed.

A case of HIV-associated generalized syphilitic alopecia mimicking alopecia universalis.

T-Cell-Driven Fibroinflammation Inducing Follicular Dedifferentiation in Alopecia Areata and IgG4-Modified Disease.

Unexpected hair regrowth in a woman with longstanding Alopecia universalis.